Annual Working Capital
$300.60 M
-$19.13 M-5.98%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual working capital is $300.60 million, with the most recent change of -$19.13 million (-5.98%) on December 31, 2023.
- During the last 3 years, TNGX annual working capital has risen by +$147.88 million (+96.84%).
- TNGX annual working capital is now -33.44% below its all-time high of $451.65 million, reached on December 31, 2021.
Performance
TNGX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$263.23 M
-$21.31 M-7.49%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly working capital is $263.23 million, with the most recent change of -$21.31 million (-7.49%) on September 30, 2024.
- Over the past year, TNGX quarterly working capital has dropped by -$37.37 million (-12.43%).
- TNGX quarterly working capital is now -44.51% below its all-time high of $474.35 million, reached on September 30, 2021.
Performance
TNGX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TNGX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | -12.4% |
| 3 y3 years | +96.8% | -9.0% |
| 5 y5 years | +96.8% | -9.0% |
TNGX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.4% | at low | -41.7% | at low |
| 5 y | 5-year | -33.4% | +96.8% | -44.5% | +72.4% |
| alltime | all time | -33.4% | +96.8% | -44.5% | +72.4% |
Tango Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $263.23 M(-7.5%) |
| Jun 2024 | - | $284.54 M(-8.0%) |
| Mar 2024 | - | $309.25 M(+2.9%) |
| Dec 2023 | $300.60 M(-6.0%) | $300.60 M(-8.2%) |
| Sep 2023 | - | $327.48 M(+22.7%) |
| Jun 2023 | - | $266.91 M(-7.7%) |
| Mar 2023 | - | $289.33 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $319.73 M(-29.2%) | $319.73 M(-8.7%) |
| Sep 2022 | - | $350.35 M(-10.5%) |
| Jun 2022 | - | $391.40 M(-7.1%) |
| Mar 2022 | - | $421.44 M(-6.7%) |
| Dec 2021 | $451.65 M(+195.7%) | $451.65 M(-4.8%) |
| Sep 2021 | - | $474.35 M(+210.6%) |
| Dec 2020 | $152.72 M | $152.72 M |
FAQ
- What is Tango Therapeutics annual working capital?
- What is the all time high annual working capital for Tango Therapeutics?
- What is Tango Therapeutics annual working capital year-on-year change?
- What is Tango Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Tango Therapeutics?
- What is Tango Therapeutics quarterly working capital year-on-year change?
What is Tango Therapeutics annual working capital?
The current annual working capital of TNGX is $300.60 M
What is the all time high annual working capital for Tango Therapeutics?
Tango Therapeutics all-time high annual working capital is $451.65 M
What is Tango Therapeutics annual working capital year-on-year change?
Over the past year, TNGX annual working capital has changed by -$19.13 M (-5.98%)
What is Tango Therapeutics quarterly working capital?
The current quarterly working capital of TNGX is $263.23 M
What is the all time high quarterly working capital for Tango Therapeutics?
Tango Therapeutics all-time high quarterly working capital is $474.35 M
What is Tango Therapeutics quarterly working capital year-on-year change?
Over the past year, TNGX quarterly working capital has changed by -$37.37 M (-12.43%)